Literature DB >> 34158503

Repurposing tRNAs for nonsense suppression.

Suki Albers1, Bertrand Beckert1, Marco C Matthies2, Chandra Sekhar Mandava3, Raphael Schuster4, Carolin Seuring5, Maria Riedner4, Suparna Sanyal3, Andrew E Torda2, Daniel N Wilson1, Zoya Ignatova6.   

Abstract

Three stop codons (UAA, UAG and UGA) terminate protein synthesis and are almost exclusively recognized by release factors. Here, we design de novo transfer RNAs (tRNAs) that efficiently decode UGA stop codons in Escherichia coli. The tRNA designs harness various functionally conserved aspects of sense-codon decoding tRNAs. Optimization within the TΨC-stem to stabilize binding to the elongation factor, displays the most potent effect in enhancing suppression activity. We determine the structure of the ribosome in a complex with the designed tRNA bound to a UGA stop codon in the A site at 2.9 Å resolution. In the context of the suppressor tRNA, the conformation of the UGA codon resembles that of a sense-codon rather than when canonical translation termination release factors are bound, suggesting conformational flexibility of the stop codons dependent on the nature of the A-site ligand. The systematic analysis, combined with structural insights, provides a rationale for targeted repurposing of tRNAs to correct devastating nonsense mutations that introduce a premature stop codon.

Entities:  

Year:  2021        PMID: 34158503     DOI: 10.1038/s41467-021-24076-x

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  63 in total

Review 1.  Structural aspects of translation termination on the ribosome.

Authors:  Andrei A Korostelev
Journal:  RNA       Date:  2011-06-23       Impact factor: 4.942

Review 2.  Emerging roles of tRNA in adaptive translation, signalling dynamics and disease.

Authors:  Sebastian Kirchner; Zoya Ignatova
Journal:  Nat Rev Genet       Date:  2014-12-23       Impact factor: 53.242

Review 3.  Transfer ribonucleic acid-mediated suppression of termination codons in Escherichia coli.

Authors:  G Eggertsson; D Söll
Journal:  Microbiol Rev       Date:  1988-09

4.  Partial functional correction of xeroderma pigmentosum group A cells by suppressor tRNA.

Authors:  R G Panchal; S Wang; J McDermott; C J Link
Journal:  Hum Gene Ther       Date:  1999-09-01       Impact factor: 5.695

5.  Suppression of nonsense mutations in cell culture and mice by multimerized suppressor tRNA genes.

Authors:  M Buvoli; A Buvoli; L A Leinwand
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

6.  Construction of a functional human suppressor tRNA gene: an approach to gene therapy for beta-thalassaemia.

Authors:  G F Temple; A M Dozy; K L Roy; Y W Kan
Journal:  Nature       Date:  1982-04-08       Impact factor: 49.962

7.  Origin of the omnipotence of eukaryotic release factor 1.

Authors:  Christoffer Lind; Ana Oliveira; Johan Åqvist
Journal:  Nat Commun       Date:  2017-11-10       Impact factor: 14.919

Review 8.  Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons.

Authors:  Maciej Dabrowski; Zuzanna Bukowy-Bieryllo; Ewa Zietkiewicz
Journal:  Mol Med       Date:  2018-05-29       Impact factor: 6.354

9.  GtRNAdb: a database of transfer RNA genes detected in genomic sequence.

Authors:  Patricia P Chan; Todd M Lowe
Journal:  Nucleic Acids Res       Date:  2008-11-04       Impact factor: 16.971

10.  Genetic Codes with No Dedicated Stop Codon: Context-Dependent Translation Termination.

Authors:  Estienne Carl Swart; Valentina Serra; Giulio Petroni; Mariusz Nowacki
Journal:  Cell       Date:  2016-07-14       Impact factor: 41.582

View more
  2 in total

1.  Immunoprecipation Assay to Quantify the Amount of tRNAs associated with Their Interacting Proteins in Tissue and Cell Culture.

Authors:  Sarada Das; Amila Zuko; Robin Thompson; Erik Storkebaum; Zoya Ignatova
Journal:  Bio Protoc       Date:  2022-02-20

Review 2.  GENE TARGET: A framework for evaluating Mendelian neurodevelopmental disorders for gene therapy.

Authors:  Maya Chopra; Meera E Modi; Kira A Dies; Nancy L Chamberlin; Elizabeth D Buttermore; Stephanie Jo Brewster; Lisa Prock; Mustafa Sahin
Journal:  Mol Ther Methods Clin Dev       Date:  2022-08-29       Impact factor: 5.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.